Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Mules

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Alimentary Pharmacology & Therapeutics|July 26, 2022
Editorial: measuring disease severity in inflammatory bowel disease-the whole is greater than the sum of its parts. Authors' replyAkhilesh Swaminathan, Thomas C Mules, Richard B Gearry
Alimentary Pharmacology & Therapeutics|October 26, 2021
Editorial: brain-gut research needs objective measures of disease activity and mental disorders-authors' replyThomas C Mules, Akhilesh Swaminathan, Richard B Gearry
Allergy|July 14, 2023
Helminths' therapeutic potential to treat intestinal barrier dysfunctionThomas C Mules, Stephen Inns, Graham Le Gros
Frontiers in Medicine|July 11, 2025
Non-invasive biomarkers to diagnose and monitor eosinophilic esophagitis: a systematic reviewSophia-Louise Noble, Richard Tyrrell, Thomas C Mules, et al.
Immunology and Cell Biology|September 13, 2024
The immunoregulatory potential of eosinophil subsetsSophia-Louise Noble, Thomas C Mules, Graham Le Gros, et al.
Journal of the Royal Society of New Zealand|July 28, 2025
Translating evidence into action: overcoming barriers to gastric cancer prevention in AotearoaCameron Schauer, Andrea Teng, Virgina Signal, et al.
Immunology and Cell Biology|June 26, 2024
Helminth infection induces a distinct subset of CD101<sup>hi</sup> lung tissue-infiltrating eosinophils that are differentially regulated by type 2 cytokinesSophia-Louise Noble, Francesco Vacca, Kerry L Hilligan, et al.
Alimentary Pharmacology & Therapeutics|September 29, 2021
The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease-results from the Stress, Anxiety and Depression with Disease Activity (SADD) StudyThomas C Mules, Akhilesh Swaminathan, Esther Hirschfeld, et al.
Inflammatory Bowel Diseases|September 27, 2022
The Impact of Disease Activity on Sexual and Erectile Dysfunction in Patients With Inflammatory Bowel DiseaseThomas C Mules, Akhilesh Swaminathan, Esther Hirschfeld, et al.
Alimentary Pharmacology & Therapeutics|May 28, 2022
The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease courseAkhilesh Swaminathan, Dali Fan, Grace M Borichevsky, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Alimentary Pharmacology & Therapeutics|July 26, 2022
Editorial: measuring disease severity in inflammatory bowel disease-the whole is greater than the sum of its parts. Authors' replyAkhilesh Swaminathan, Thomas C Mules, Richard B Gearry
Alimentary Pharmacology & Therapeutics|October 26, 2021
Editorial: brain-gut research needs objective measures of disease activity and mental disorders-authors' replyThomas C Mules, Akhilesh Swaminathan, Richard B Gearry
Allergy|July 14, 2023
Helminths' therapeutic potential to treat intestinal barrier dysfunctionThomas C Mules, Stephen Inns, Graham Le Gros
Frontiers in Medicine|July 11, 2025
Non-invasive biomarkers to diagnose and monitor eosinophilic esophagitis: a systematic reviewSophia-Louise Noble, Richard Tyrrell, Thomas C Mules, et al.
Immunology and Cell Biology|September 13, 2024
The immunoregulatory potential of eosinophil subsetsSophia-Louise Noble, Thomas C Mules, Graham Le Gros, et al.
Journal of the Royal Society of New Zealand|July 28, 2025
Translating evidence into action: overcoming barriers to gastric cancer prevention in AotearoaCameron Schauer, Andrea Teng, Virgina Signal, et al.
Immunology and Cell Biology|June 26, 2024
Helminth infection induces a distinct subset of CD101<sup>hi</sup> lung tissue-infiltrating eosinophils that are differentially regulated by type 2 cytokinesSophia-Louise Noble, Francesco Vacca, Kerry L Hilligan, et al.
Alimentary Pharmacology & Therapeutics|September 29, 2021
The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease-results from the Stress, Anxiety and Depression with Disease Activity (SADD) StudyThomas C Mules, Akhilesh Swaminathan, Esther Hirschfeld, et al.
Inflammatory Bowel Diseases|September 27, 2022
The Impact of Disease Activity on Sexual and Erectile Dysfunction in Patients With Inflammatory Bowel DiseaseThomas C Mules, Akhilesh Swaminathan, Esther Hirschfeld, et al.
Alimentary Pharmacology & Therapeutics|May 28, 2022
The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease courseAkhilesh Swaminathan, Dali Fan, Grace M Borichevsky, et al.
Pageof 2